Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Infants born prematurely (before completion of 37 weeks of gestation) are at increased risk of morbidity and mortality due to vaccine preventable diseases, mostly because of their immunological immaturity and failure of transfer of maternal protective antibodies. Despite their great need of being vaccinated, concerns on vaccine safety and efficacy, constitute the main reasons for which vaccinations are often delayed in this group. In this review we summarize the latest evidence on vaccine safety, efficacy and immunogenicity in preterm infants which is similar to full-term infants. Therefore there is no reason for delaying vaccination in this population.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396316666200116094459
2020-05-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396316666200116094459
Loading

  • Article Type:
    Review Article
Keyword(s): born; immunization; immunogenicity; morbidity; mortality; premature infants; Vaccinations
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test